A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection.

Mars Inc. has licensed agricultural gene editing firm Pairwise's Fulcrum gene editing platform to boost cacao research and ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Ancient events in plant evolution have left behind large, duplicated regions in their genomes. Salk Institute scientists ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Releasing a newly-identified molecular brake that hinders the ability of T cells to attack tumors could supercharge ...

There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain ...

To tackle this question at a Ph.D. level, you'd need to explore various theories of consciousness, from dualism to ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

As transformative as they may be for patients, cell and gene therapies are creating new kinds of uncertainty and challenges ...

Data from a new study elucidates the role of a transcriptional enhancer dubbed HAR123 in neural cell development and cognitive flexibility.